Long-term clinical course and visual outcome associated with Peters' anomaly

Eye
J W ChangY S Yu

Abstract

To investigate the long-term clinical course and visual outcomes of Peters' anomaly cases treated with various treatment modalities. All patients with Peters' anomaly treated at Seoul National University Children's Hospital from 1985 to 2005 were reviewed retrospectively. Patients who were followed for more than 5 years after the first visit were enrolled for analysis of the visual outcome. Final visual outcomes were presented with respect to disease severity and treatment modalities. Disease severity was determined according to the corneal status and accompanied eye anomalies in mild or severe form. Treatment plans were classified into the following groups: (1) a medical treatment group; (2) a surgical treatment group; and (3) a no-treatment group. A total of 106 eyes in 76 patients were diagnosed as Peters' anomaly, and 90 eyes in 65 patients were analysed regarding the visual outcome. Overall, 60 eyes (67%) had severe disease, and 30 eyes (33%) had mild disease. Twenty-six eyes (29%) received medical treatment, 44 eyes (49%) received surgical treatment, and 20 eyes (22%) received no treatment. The mean final visual acuity was 1.415 logMAR, 2.344 logMAR, and 2.282 logMAR, respectively. The visual outcomes of the eyes with mil...Continue Reading

References

Jul 1, 1975·Survey of Ophthalmology·G O WaringPeter R Laibson
Feb 1, 1976·American Journal of Ophthalmology·D L StoneS J Ryan
Oct 1, 1971·American Journal of Ophthalmology·I Nakanishi, S I Brown
Mar 1, 1966·Archives of Ophthalmology·A B Reese, R M Ellsworth
Aug 1, 1996·Klinische Monatsblätter für Augenheilkunde·A JünemannG O Naumann
Dec 29, 2000·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·H OzekiY Ogura
Mar 1, 2006·Investigative Ophthalmology & Visual Science·Kilian Schulze-BonselMichael Bach
Jul 3, 2007·American Journal of Ophthalmology·Gerald ZaidmanCatherine C Furey
Jul 25, 2008·Cornea·Kavita V RaoVirender S Sangwan
Apr 28, 2009·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Lucy L H YangR D Stulting
Sep 3, 2009·Cornea·Charles HuangMark J Mannis
Oct 12, 2010·Ophthalmology·Marie T LoweKeryn A Williams
Feb 8, 2011·European Journal of Ophthalmology·Chrysanthi BasdekidouGeorges Caputo
Mar 23, 2011·Journal of Cataract and Refractive Surgery·Clara C Chan, Edward J Holland

Citations

Feb 17, 2017·Cornea·Haruna YoshikawaShigeru Kinoshita
May 10, 2017·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·S ReichlT Reinhard
May 8, 2013·Ophthalmology and Eye Diseases·Robert W Sault, Jeffrey Sheridan
Feb 7, 2018·Cornea·Yu Qiang Soh, Jodhbir S Mehta
Jul 31, 2018·Journal of Glaucoma·Ta C ChangElizabeth A Vanner
Feb 29, 2020·Paediatric Anaesthesia·Irim SalikSamuel Barst
Apr 14, 2020·Journal of Ophthalmology·Wen-Si ChenLan-Xiang Hu
May 3, 2018·Pediatrics in Review·Brandon WangAdrian Bayona

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.

Related Papers

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Ji Woong ChangYoung Suk Yu
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
Lucy L H YangR D Stulting
Cornea
Ramanath BhandariDouglas R Lazzaro
© 2021 Meta ULC. All rights reserved